| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9639 |
| Human Intestinal Absorption | HIA+ | 0.9841 |
| Caco-2 Permeability | Caco2+ | 0.5644 |
| P-glycoprotein Substrate | Non-substrate | 0.8563 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9888 |
| Non-inhibitor | 0.9904 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9472 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6703 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7598 |
| CYP450 2D6 Substrate | Non-substrate | 0.9517 |
| CYP450 3A4 Substrate | Non-substrate | 0.8093 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9406 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9695 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9729 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9907 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9827 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9930 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9770 |
| Non-inhibitor | 0.9876 |
| AMES Toxicity | Non AMES toxic | 0.9815 |
| Carcinogens | Carcinogens | 0.6452 |
| Fish Toxicity | Low FHMT | 0.6462 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9428 |
| Honey Bee Toxicity | High HBT | 0.7866 |
| Biodegradation | Ready biodegradable | 0.9069 |
| Acute Oral Toxicity | III | 0.7890 |
| Carcinogenicity (Three-class) | Non-required | 0.7376 |